OS-090 Novel epigenetic editing technology targets hepatitis B virus in vivo to deeply and durably repress viral markers von Anglero-Rodriguez, Yesseinia, Abubucker, Sahar, Xiong, John, Medina, Jhon, Mugambwa, Caroline, Choo-wing, Rayman, Jacques, Carrietta, Acosta, Glen, Clarkson, Scott, Bayne, Kendra, Morrison, Mary, Friedland, Ari, Wong, Narayan, Hoque, Zohan, DiPiazza, Amber, Koppana, Parthu, Hung, Kuo-Chan, Abraham, Sameer, Zhai, Adam, Spinelli, Pietro, Myer, Vic, Jaffe, Aron

Volltext